(Q28290097)
Statements
The flawed basis for FDA post-marketing safety decisions: the example of anti-depressants and children (English)
0 references
April 2006
0 references
31
0 references
4
0 references
689-99
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference